A5061533554- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Immunotherapy and Biomarkers
- Breast Lesions and Carcinomas
- Breast Cancer Treatment Studies
- Colorectal and Anal Carcinomas
- Cervical Cancer and HPV Research
- Ovarian cancer diagnosis and treatment
- Inflammatory Biomarkers in Disease Prognosis
- Endometrial and Cervical Cancer Treatments
- Head and Neck Cancer Studies
- Advanced Radiotherapy Techniques
- Advances in Oncology and Radiotherapy
- Brain Metastases and Treatment
- Cancer Treatment and Pharmacology
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Neuroendocrine Tumor Research Advances
- Radiomics and Machine Learning in Medical Imaging
- Liver Disease Diagnosis and Treatment
- Metastasis and carcinoma case studies
- Innovations in Medical Education
- Neuroblastoma Research and Treatments
- Colorectal Cancer Surgical Treatments
University of North Carolina at Chapel Hill
2018-2024
University of North Carolina Hospitals
2018-2023
Cornell University
2021
The Bronx Defenders
2021
Montefiore Medical Center
2018-2021
Albert Einstein College of Medicine
2019-2021
Washington University in St. Louis
2014-2018
Merck (Germany)
2016
Bayer (United States)
2016
Elekta (Switzerland)
2016
As the utility of Child-Pugh (C-P) class is limited by subjectivity ascites and encephalopathy, we evaluated a previously established objective method, albumin-bilirubin (ALBI) grade, as prognosticator for yttrium-90 radioembolization (RE) treatment patients with hepatocellular carcinoma (HCC).A total 117 who received RE HCC from 2 academic centers were reviewed stratified ALBI C-P class, Barcelona Clinic Liver Cancer stage. The overall survival (OS) according to these 3 criteria was...
F-fluorodeoxyglucose (FDG) positron emission tomography-(PET)/computed tomography (CT) imaging is used for staging and treatment planning of patients with anal cancer. Quantitative pre- posttreatment metrics that are predictive recurrence unknown. We evaluated the association between FDG-PET/CT parameters outcomes squamous cell carcinoma anus (SCCA).
The prognosis of patients with hepatic metastases from neuroendocrine tumors (NET) is generally good, and radioembolization Yttrium-90 microspheres a locoregional therapy that used in efforts to improve disease control survival. This study aims describe the survival outcomes toxicities associated for hepatic-predominant metastatic NET large single-institution cohort.A total 59 underwent predominant at single academic center. Patient were analyzed by Kaplan-Meier analysis detailed described....
The importance of invasive mediastinal nodal staging in early-stage non-small cell lung cancer (NSCLC) the PET/CT era is dependent on tumor factors that increase risk metastasis. At our institution, patients undergo biopsy via either CT-guidance (without staging) or navigational bronchoscopy with endobronchial ultrasound transbronchial needle aspiration for staging. This study aims to compare outcomes after stereotactic body radiotherapy (SBRT) stratified by receipt staging.In this...
In premenopausal women with hormone dependent breast cancers, ovarian suppression is an important part of treatment, and often achieved a bilateral salpingo-oophorectomy (BSO). However, this procedure can lead to remnant syndrome (ORS), rare condition where the adnexal tissue not completely removed produce estrogen. We describe case ORS in patient estrogen receptor positive (ER+) cancer who had progression disease after undergoing BSO, despite optimal therapy. therefore poses significant...
Abstract Background: Immune regulation plays an important role in tumor growth and sustainability. The neutrophil-to-lymphocyte ratio (NLR) platelet-to-lymphocyte (PLR) have been reported as peripheral blood surrogates of inflammation immune response, studied prognostic markers treatment response breast cancer. Cyclin-dependent kinase (CDK) 4/6 inhibitors shown to enhance the against cells. We aimed evaluate impact NLR PLR biomarkers patients with estrogen-receptor positive (ER+),...